Consistent with our results showing an additive effect of dual PTPN2/N1 inhibition in tumour cells, AC484 increased the expression of CD69 in PTPN2-deficient or PTPN1-deficient T cells (Fig. 2h). The gene discussed is PTPN1; the disease is neoplasm.